Global Clinical Trial Supplies Market size is estimated to record USD 2.64 billion by 2026, at a Compound Annual Growth Rate (CAGR) of 7.6%.
Clinical Trial Supplies Market report (2019-2026) includes global market size, trends, company overview, competition analysis, and forecast. The global market is projected to record USD 1.58 Billion in 2019.
The market report includes Clinical Trial Supplies market definition, segmentation, executive summary, value chain analysis, porter’s analysis, research methodology and new industry trends which includes drivers, restraints and market opportunities. Other section includes regional analysis which is conducted on various factors such as cost of the product/services, raw material supplies, production capacities, availability and demand analysis. Further section includes analysis and opportunity assessment for key companies. This section includes competition analysis, market share analysis, key developments of the industry, and company profiling. Within company profiling, detailed analysis of key players including company overview, financial information analysis, product offerings, and recent development of company. This also includes SWOT analysis that highlights the current position of company among competitors and in market.
Clinical Trial Supplies Market Dynamics
The market report comprises of market dynamics/trends section that includes driving factors, restraints, and opportunities faced by the market players and stakeholders. These market trends includes core factors such as driving factor and restraining factor and extrinsic factors such as opportunities. These factors are not only confined with the current market situation as well as with the forecasted period.
Clinical Trial Supplies Market Competitive Landscape
The key companies in Clinical Trial Supplies Market are Roche, Abbott, BioM?rieux, Abaxis, Siemens Healthineers, QIAGEN, Danaher, Instrumentation Laboratory, Nova Biomedical, Quidel, Trinity Biotech, Sekisui Diagnostics.
Focus Areas of Market
• Global Market Analysis (2019-2026)
• Cost Analysis
• Market Growth Factors
• Market Strategies
• Key Companies Analysis
• Industry Growth Analysis
Regional Analysis
• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa
Company Profile Inclusions
• Business Overview
• Financial Information
• Market Share Analysis
• Recent News
• SWOT Analysis
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
Chapter 4. Market Outlook
4.1. Market Dynamics
4.1.1. Market Drivers
4.1.2. Market Restraints
4.1.3. Market Opportunities
4.2. Porter’s Analysis
4.3. Value Chain Analysis
Chapter 5. Clinical Trial Supplies Industry, By Service
5.1. Clinical Trial Supplies Market, By Service 2019-2026
5.2. Manufacturing
5.3. Packaging, Labeling, and Blinding
5.4. Comparator Sourcing
5.5. Logistics
5.6. Distribution, Storage, and Retention
5.7. Solutions
Chapter 6. Clinical Trial Supplies Industry, By Therapeutic Area
6.1. Clinical Trial Supplies Market, By Therapeutic Area 2019-2026
6.2. Oncology
6.3. Neurological and Mental Disorders
6.4. Infectious and Immune System Diseases
6.5. Digestive System Diseases
6.6. Blood Disorders
6.7. Other
Chapter 7. Clinical Trial Supplies Industry, By Region
7.1. Clinical Trial Supplies Market, By Region 2019-2026
7.1.1. North America
7.1.1.1. U.S
7.1.1.1. Canada
7.1.1.2. Mexico
7.1.2. Europe
7.1.2.1. U.K.
7.1.2.2. Germany
7.1.2.3. France
7.1.2.4. Rest of the Europe
7.1.3. Middle East & Africa (MEA)
7.1.3.1. GCC
7.1.3.2. North Africa
7.1.3.3. South Africa
7.1.3.4. Rest of MEA
7.1.4. Latin America (LATAM)
7.1.4.1. Brazil
7.1.4.2. Rest of LATAM
7.1.5. Asia Pacific (APAC)
7.1.5.1. India
7.1.5.2. China
7.1.5.3. Japan
7.1.5.4. Rest of the APAC
Chapter 8. Competitive Landscape
8.1.1. Key Strategies Adopted by Players
8.1.2. Market Share/Positioning Analysis
Chapter 9. Company Profiles
9.1. Alamc Group
9.1.1. Company Overview
9.1.2. Product Offerings
9.1.3. Financial Performance
9.1.4. Recent Initiatives
9.2. Catalent, Inc.
9.3. PCI Services
9.4. Parexel International Corporation
9.5. Sharp Packaging Services
9.6. Biocair
9.7. O&M Movianto
9.8. KLIFO A/S
9.9. Thermo Fisher Scientific, Inc.
9.10. Capsugel
9.11. UDG Healthcare Plc.
9.12. Bilcare Limited
Chapter 10. Appendix
10.1. About Us
10.2. Glossary of Terms
10.3. Disclaimer
1. Alamc Group
2. Catalent, Inc.
3. PCI Services
4. Parexel International Corporation
5. Sharp Packaging Services
6. Biocair
7. O&M Movianto
8. KLIFO A/S
9. Thermo Fisher Scientific, Inc.
10. Capsugel
11. UDG Healthcare Plc.
12. Bilcare Limited